CRI Gujarat Recruitment 2017 - 43 Medical Officer, Senior Resident & Various Vacancies

GCRI Recruitment 2017 - 43 Medical Officer, Senior Resident & Various Vacancies 

CRI-Gujarat-jobs-43-MO-Resident

Gujarat Cancer and Research Institute (GCRI) has invited application for the post of 43 Medical Officer, Senior Resident & Various Vacancies. Apply before 20 March 2017. All the Candidates who are fighting for the Government jobs, should keep in mind this is the best oppertunity for You and must fill up the form. You must read through out the advertisement before applying for the post. For more details regarding age limit, educational qualification, selection process and how to apply and other, read the details given below.
Complete Details of the Vacancy
Total No. of Posts: 43 Posts
[post_ads]
Name of the Post: Medical Officer
  • No. of Vacancy : 08 Posts
  • Pay Scale : Rs. 35000/- (Per Month)
Name of the Post: Senior Resident
  • No. of Vacancy : 05 Posts
  • Pay Scale : Rs. 46000/- (Per Month)
Age Limit: Maximum age limit is 35 years as on 20.03.2017

Job Location : Ahmedabad (Gujarat)

Educational Qualification:
  • For Medical Officer : M.B.B.S. from Government Recognized Institute with two years experience.
  • For Senior Resident : D.N.B / D.M in Medical Oncology/ Surgical Oncology/ Gynaecology with three years experience.
Nationality : Indian

Selection Process: Selection will be through interview.

Application Fee : There is no application fee.

How to Apply:
Interested candidates may apply in prescribed application form along with attested photocopies of all the relevant documents, experience certificates & one recent colour passport size photograph send to The Incharge Director, The Gujarat Cancer & Research Institute, Civil Hospital Campus, Asarwa, Ahmedabad–380016 on or before 20.03.2017.

Last Date for Receipt of Application: 20.03.2017

For more details regarding age limit, educational qualification, selection process and how to apply and other, click on the following link to See the advertisement.

[post_ads_2]

Comments